Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: Evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy
Wt. Lee et al., Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: Evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy, NEUROSCIENC, 95(1), 2000, pp. 89-95
Magnetic resonance imaging and in vivo proton magnetic resonance spectrosco
py were used to evaluate the therapeutic effect of lamotrigine and MK-801 o
n rat brain lesions induced by 3-nitropropionic acid. Systemic administrati
on of 3-nitropropionic acid (15 mg/kg per day) to two-month-old Sprague-Daw
ley rats (n = 10 for each group) for five consecutive days induced selectiv
e striatal and hippocampal lesions and specific behavioral change. Pretreat
ment with lamotrigine(10 mg/kg or 20 mg/kg per day) or MK-801 (2 mg/kg per
day) attenuated the lesions and behavioral change. There were no significan
t differences in T2 values of the striatum and hippocampus among rats pretr
eated with MK-801, lamotrigine (20 mg/kg) and sham controls. Significant el
evations of succinate/creatine and lactate/creatine ratios and decreases of
N-acetylaspartate/creatine and choline/creatine ratios were observed after
3-nitropropionic acid injections (P < 0.001). The changes were nearly prev
ented after pretreatment with lamotrigine (20 mg/kg). However, the N-acetyl
aspartate/creatine in rats pretreated with lamotrigine (10 mg/kg) (P < 0.01
) and MK-801 (P < 0.05) still showed significant reduction as compared with
sham controls.
Thus we conclude that both lamotrigine and MK-801 are effective in attenuat
ion of brain lesions induced by 3-nitropropionic acid. A higher dose of lam
otrigine provides a better neuroprotective effect than MK-801. With a bette
r therapeutic effect and fewer side effects, lamotrigine is more promising
for potential clinical application. (C) 1999 IBRO. Published by Elsevier Sc
ience Ltd.